TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

Reset
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
SEPN Long Daniel D. SVP, Drug Discovery 09/01/2026 Verkauf 37.83 3,333 126,078 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 09/01/2026 Optionsausübung 2.76 3,333 9,199 Form 4
SEPN Ra Capital Management, L.p. Director 08/12/2026 Verkauf 42.50 746,500 31,726,250 Form 4
SEPN Third Rock Ventures V, L.P. 10% Owner 08/12/2026 Verkauf 51.08 141 7,202 Form 4
SEPN Third Rock Ventures V, L.P. 10% Owner 08/12/2026 Verkauf 50.27 147,059 7,392,656 Form 4
SEPN Bhatt Elizabeth President and COO 08/11/2026 Verkauf 44.00 25,000 1,100,000 Form 4
SEPN Bhatt Elizabeth President and COO 08/11/2026 Optionsausübung 2.76 6,319 17,440 Form 4
SEPN Bhatt Elizabeth President and COO 08/11/2026 Optionsausübung 6.81 18,681 127,218 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 08/03/2026 Verkauf 34.68 2,334 80,944 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 08/03/2026 Verkauf 33.98 1,000 33,976 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 08/03/2026 Optionsausübung 2.76 1,518 4,190 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 08/03/2026 Optionsausübung 2.76 1,816 5,012 Form 4
SEPN Bhatt Elizabeth President and COO 07/15/2026 Verkauf 33.99 4,000 135,974 Form 4
SEPN Bhatt Elizabeth President and COO 07/15/2026 Optionsausübung 6.81 4,000 27,240 Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?